Hepatocyte nuclear factor-4␣ (HNF4␣) is known as the master regulator of hepatocyte differentiation. Recent studies indicate that HNF4␣ may inhibit hepatocyte proliferation via mechanisms that have yet to be identified. Using a HNF4␣ knockdown mouse model based on delivery of inducible Cre recombinase via an adeno-associated virus 8 viral vector, we investigated the role of HNF4␣ in the regulation of hepatocyte proliferation. Hepatocyte-specific deletion of HNF4␣ resulted in increased hepatocyte proliferation. Global gene expression analysis showed that a majority of the downregulated genes were previously known HNF4␣ target genes involved in hepatic differentiation. Interestingly, Ն500 upregulated genes were associated with cell proliferation and cancer. Furthermore, we identified potential negative target genes of HNF4␣, many of which are involved in the stimulation of proliferation. Using chromatin immunoprecipitation analysis, we confirmed binding of HNF4␣ at three of these genes. Furthermore, overexpression of HNF4␣ in mouse hepatocellular carcinoma cells resulted in a decrease in promitogenic gene expression and cell cycle arrest. Taken together, these data indicate that, apart from its role in hepatocyte differentiation, HNF4␣ actively inhibits hepatocyte proliferation by repression of specific promitogenic genes. adeno-associated virus; Ect2; gene repression; hepatocyte proliferation; liver regeneration THE LIVER IS KNOWN for its exceptional capability to regenerate in response to surgical removal, as well as following druginduced liver injury. Liver regeneration is critical in maintaining liver health, because the liver is the major site of xenobiotic detoxification and is exposed to a variety of drugs and chemicals. The mechanisms of initiation and progression of liver regeneration are well studied, but the mechanisms of termination of regeneration are not completely understood (27). It is important to understand the mechanisms of termination of liver regeneration, because many of the pathways involved in stimulation of liver regeneration can be carcinogenic if left unchecked. It is known that the mechanisms of termination of regeneration are essential to maintain controlled liver growth and inhibit progression to hepatocellular carcinoma (HCC). However, the detailed mechanisms of termination of regeneration and their link to prevention of HCC are not completely clear.
THE LIVER IS KNOWN for its exceptional capability to regenerate in response to surgical removal, as well as following druginduced liver injury. Liver regeneration is critical in maintaining liver health, because the liver is the major site of xenobiotic detoxification and is exposed to a variety of drugs and chemicals. The mechanisms of initiation and progression of liver regeneration are well studied, but the mechanisms of termination of regeneration are not completely understood (27) . It is important to understand the mechanisms of termination of liver regeneration, because many of the pathways involved in stimulation of liver regeneration can be carcinogenic if left unchecked. It is known that the mechanisms of termination of regeneration are essential to maintain controlled liver growth and inhibit progression to hepatocellular carcinoma (HCC). However, the detailed mechanisms of termination of regeneration and their link to prevention of HCC are not completely clear.
Hepatocyte nuclear factor-4␣ (HNF4␣, representative public ID NR2A1) is considered the master regulator of hepatocyte differentiation. It plays an important role in the regulation of many hepatocyte-specific genes, including those involved in glycolysis, gluconeogenesis, ureagenesis, fatty acid metabolism, bile acid synthesis, drug metabolism, apolipoprotein synthesis, and blood coagulation (11, 15, 18 -21) . Recent studies suggest a novel role of HNF4␣ in the regulation of cell proliferation (8, 9, 11, 12, 15, 23, 26, 29, 36) . Data indicate that HNF4␣ may have antiproliferative activity in human embryonic kidney cells and rat pancreatic beta cells (8, 12) . In HEK-293 cells, HNF4␣ has been shown to regulate 14 promitogenic genes, including cyclin-dependent kinase inhibitor 1A (p21), transforming growth factor-␣ (TGF␣), membrane metalloendopeptidase (MME), and a disintegrin and metalloproteinase (ADAM) metallopeptidase with thrombospondin type 1 motif (ADAMTS1) (12) . It is known that loss of HNF4␣ results in rapid progression of HCC (26) , an observation supported by other studies indicating decreased HNF4␣ expression in HCC compared with adjacent normal liver tissues in mouse, rat, and human (9, 23, 36) . Similarly, Ning et al. (29) reported that overexpression of HNF4␣ suppresses diethylnitrosamine-induced HCC in rats. Another recent study indicates that deletion of HNF4␣ results in increased hepatocyte proliferation (4) . These data suggest that HNF4␣ may have the ability to inhibit hepatocyte proliferation within the liver; however, the mechanisms are yet to be determined. Additionally, the role of HNF4␣ in initiation and termination of liver regeneration after partial hepatectomy or toxic injury remains unknown. Thus the primary goal of this study was to determine the role and mechanisms of HNF4␣ in the regulation of hepatocyte proliferation in normal, quiescent hepatocytes. It is important to define the mechanisms of HNF4␣-mediated inhibition of hepatocyte proliferation, because elucidation of these mechanisms will highlight HNF4␣ as a therapeutic target for HCC and other chronic liver diseases.
MATERIALS AND METHODS

Animals, treatments, and tissue collection. The HNF4␣
fl/fl mice (a kind gift from Dr. Frank Gonzalez, National Cancer Institute) are described elsewhere (15) . All animals were housed in Association for Assessment and Accreditation of Laboratory Animal Care-accredited facilities at the University of Kansas Medical Center (KUMC) under a standard 12:12-h light-dark cycle with access to chow and water ad libitum. All studies were approved by the Institutional Animal Care and Use Committee of KUMC. Three-month-old HNF4␣ fl/fl mice were treated with an adeno-associated virus 8 (AAV8) containing the gene for Cre recombinase under the control of the murine major urinary protein (MUP) promoter (MUP-iCre-AAV8) or a control AAV8 expressing the gene for green fluorescent protein (GFP) under the control of the same element (MUP-EGFP-AAV8) (Fig. 1A) . The viral vectors were prepared as previously described (16) . Each mouse (n ϭ 7) received a single injection of 400 l of MUP-iCre-AAV8 or MUP-EGFP-AAV8 (titer 10 12 genome copies/ml) intraperitoneally in three separate experiments. Only male mice were used, because the MUP promoter exhibits nearly fivefold higher expression in male than female mice (13) .
Mice were killed by cervical dislocation under isoflurane anesthesia, and livers were collected. Pieces of liver were fixed in 10% neutral buffered formalin for 48 h and further processed to obtain paraffin blocks, which were sliced into 4-m-thick sections. A piece of liver was frozen in optimum cutting temperature compound (OCT) and used to prepare fresh frozen sections. A part of the liver tissue was used to prepare fresh nuclear and cytoplasmic protein extracts using the NE-PER nuclear and cytoplasmic extraction reagents (Thermo Fisher Scientific, Waltham, MA). The remaining liver tissue was frozen in liquid N 2 and stored at Ϫ80°C until it was used to isolate RNA and to prepare radioimmunoprecipitation assay (RIPA) extracts.
Western blotting. RIPA extracts obtained from whole liver tissues were used for Western blot analysis. Total protein was isolated using 1% SDS in RIPA buffer (20 mM Tris·HCl, pH 7.5, 150 mM NaCl, 0.5% NP-40, 1% Triton X-100, 0.25% sodium deoxycholate, 0.6 -2 g/ml aprotinin, and 10 M pepstatin). Protein concentrations were determined using the bicinchoninic acid (BCA) protein assay reagents (BCA method; Pierce Chemical, Rockford, IL).
Western blotting was performed using a previously described protocol (1) . In summary, total cell lysates were prepared in RIPA buffer (50 g), separated by SDS-PAGE in 4 -12% NuPage Bis-Tris gradient gels with MOPS buffer (Invitrogen, Carlsbad, CA), and then transferred to Immobilon-P membranes (Millipore, Bedford, MA) in NuPage transfer buffer containing 20% methanol. Membranes were stained using Ponceau S to analyze loading and transfer efficiency.
Membranes were probed using antibodies for HNF4␣ (1:1,000 dilution; catalog no. PP-H1415-00, R & D Systems, Minneapolis, MN) and ␤-actin (1:1,000 dilution; catalog no. 4970, Cell Signaling, Danvers, MA). Briefly, membranes were blocked using Blotto (2.5 M NaCl, 1 M Tris, pH 7.6, and 0.1% Tween 20) containing 5% nonfat milk. Membranes were then probed using primary and secondary antibodies in Blotto containing 1% nonfat milk, developed using SuperSignal West Pico chemiluminescence substrate (Thermo Fisher Scientific), and exposed to X-ray film (MidSci, St. Louis, MO).
Immunohistochemistry. Paraffin-embedded liver sections (4 m thick) were used for immunohistochemical staining. Slides were stained with hematoxylin-eosin using an autostainer (model CV 5030, Leica Microsystems, Buffalo Grove, IL). Paraffin-embedded sections were also stained with periodic acid-Schiff (PAS) stain to detect glycogen accumulation. Briefly, after deparaffinization, sections were oxidized in 0.5% periodic acid solution [0.5 g in double-distilled H2O (ddH2O)] for 5 min and washed in ddH2O for 5 min. Sections were then placed in Schiff reagent for 15 min, washed in tap water for 5 min, counterstained in hematoxylin for 1 min, washed with tap water again for 5 min, dehydrated, and mounted.
Cell proliferation was detected by immunostaining the paraffin sections for proliferating cell nuclear antigen (PCNA), as previously described (36, 37) .
Fresh frozen sections (5 m thick) were used to detect lipid accumulation by staining with Oil Red O. Oil Red O stock solution was made by combining 2 g of Oil Red O (Sigma-Aldrich, St. Louis, MO) with 400 ml of isopropanol. Oil Red O working solution was made fresh on the day of staining by combinating 240 ml of working solution with 160 ml of ddH2O. The working solution was then filtered using a TPP bottle-top 0.2-m filter (MidSci). Fresh frozen sections were air-dried at room temperature for 2 min and fixed with 10% formalin for 5 min. Sections were washed with running tap water for 10 min and then rinsed in 60% isopropanol to remove excess water. Sections were stained with freshly prepared Oil Red O working solution for 20 min and then rinsed in 60% isopropanol to remove excess Oil Red O. Nuclei were stained with hematoxylin for 2 min and then rinsed with tap water.
Immunofluorescence. Fresh frozen sections were used for immunofluorescent staining. Sections were allowed to warm to room temperature for ϳ2 min and then fixed in 10% formaldehyde in PBS for 15 min. Cell membranes were permeabilized in 0.1% Triton X-100 in PBS for 15 min and then washed in PBS (2 min, 3 times). Sections were blocked in 10% donkey serum in PBS for 1 h and then incubated with the primary antibodies [Ki-67 (1:500 dilution; catalog no. ab66155, Abcam, Cambridge, MA) and HNF4␣ (1:700 dilution; catalog no. PP-H1415-00, R & D Systems)], each diluted in 1% donkey serum in PBS, overnight. After they were incubated overnight, the sections were washed in PBS (2 min, 3 times) and then incubated in the secondary antibodies [Ki-67: donkey anti-rabbit 488 (1:500 dilution; catalog no. A-21206, Invitrogen); HNF4␣: donkey antimouse 594 (1:500 dilution; catalog no. A-21203, Invitrogen)] for 1 h. Sections were washed again in PBS (2 min, 3 times), and coverslips were applied with a 4',6-diaminido-2-phenylindole-containing medium (ProLong Gold Antifade Reagent with DAPI, catalog no. P-36931, Invitrogen).
Microarray analysis. Gene expression analysis for determining global changes in gene expression of HNF4␣ in mature mouse livers was carried out using the Affymetrix Mouse430_2.0 gene chip. Livers were pooled (100 mg per mouse) from three individual mice each for HNF4␣ fl/fl mice treated with MUP-iCre-AAV8 vector and HNF4␣
fl/fl mice treated with MUP-EGFP-AAV8 control vector for RNA isolation using the TRlzol Reagent with Phase Lock Gel Heavy protocol. The microarrays were background-corrected and normalized, and gene level was summarized using the Robust Multichip Average procedure (22) . The resulting logarithmically (base 2) transformed signal intensities were used to ascertain differentially expressed genes. Fold changes were calculated by transforming to the linear scale the difference in log intensity values between control and HNF4␣ knockout. All computations were performed in MATLAB (R2009b, MathWorks, Natick, MA) and the Partek Genomic suite version 6.5 (Partek, St. Louis, MO). These data have been submitted to the Gene Expression Omnibus database.
Genes found to be significantly up-or downregulated (2-fold cutoff) were uploaded to Ingenuity Pathways Analysis [IPA; Ingenuity Systems, version 7.6 (www.ingenuity.com)] for gene set enrichment analysis. IPA is an online software tool for identifying significant networks, functions, and canonical pathways associated with a set of genes based on information gathered in the Ingenuity Pathway Knowledge Base. The analysis was performed in IPA with default parameters.
Chromatin immunoprecipitation-sequencing data analysis. Previously published chromatin immunoprecipitation (ChIP)-sequencing (ChIP-Seq) data were downloaded from the National Center for Biotechnology Information Short Read Archive (Hnf4a: SRR014519.fastq,SRR014520.fastq; INPUT: SRR043782.fastq, SRR043783.fastq,SRR043784.fastq) (17) . Raw sequencing reads were aligned to the mouse genome (mm9) using bowtie-0.12.3 (25) . Binding sites were determined using model-based analysis of ChIPSeq (MACS) with default settings (38) . Binding sites were annotated by PeakAnalyzer (33) using the nearest TSS option, filtered to contain only the binding sites within 10 kb of a transcriptional start site, and joined with expression array data using custom scripts.
Real-time PCR. Gene expression was estimated by comparing mRNA levels from HNF4␣ fl/fl mice treated with MUP-iCre-AAV8 vector and HNF4␣ fl/fl mice treated with MUP-EGFP-AAV8 control vector by real-time PCR, as described elsewhere (35, 37) . Primers used for real-rime PCR include Ccnd1, Ccnb1, Ccnb2, Ccna2, Cdca3, Cdc20, Aurora kinase A, Ect2, Egr1, Polo-like kinase 1, Eid1, Ki-67, Rrm2, Osgin1, Hjurp, and Birc5 (Table 1) . Real-time PCR was conducted using SYBR Green technology on a real-time PCR system (model 7300, Applied Biosystems, Foster City, CA).
ChIP. ChIP was done using whole liver tissue from HNF4␣ fl/fl mice treated with the MUP-iCre-AAV8 vector and from HNF4␣ fl/fl mice treated with the MUP-EGFP-AAV8 control vector and a protocol adapted from a method previously published by Buchholz et al.
. Approximately 200 mg of frozen liver tissue were used for chromatin isolation from three mice of each group. Isolated chromatin was then incubated with mouse IgG (1 g; Millipore), DNA polymerase II (1 g; Millipore), and HNF4␣ (10 g; R & D Systems) antibodies for immunoprecipitation. Real-time PCR analysis was done using primers for the putative HNF4␣ binding sites identified by ChIP-Seq data analysis described above for Ect2, Osgin1, and Hjurp (Table 2) . Primers were designed for the site that contains the highest Indianapolis, IN) . The HNF4␣ overexpression plasmid was synthesized using the pTracer-EF vector (catalog no. V887-20, Invitrogen) and the mouse HNF4␣ gene (see Fig. 6A ).
Cells were plated at 1.5 ϫ 10 6 cells/plate in a 100-mm plate and allowed to grow for 24 h before transfection with HNF4␣ overexpression plasmid or empty vector. Other controls included cells treated with transfection reagent alone or DMEM alone. Cells were allowed to grow for 24 h before they were used for further analysis.
Overexpression of HNF4␣ was measured at the protein level by Western blotting. Total protein was harvested, and concentrations were estimated for all groups using RIPA buffer and the BCA protocol, as described previously. For Western blotting, 50 g of protein for each sample were incubated with the HNF4␣ antibody (1:1,000 dilution), with GAPDH (1:2,000 dilution; catalog no. 2118, Cell Signaling) used as a loading control.
Fluorescence-activated cell sorting. For selection of positively transfected cells, fluorescence-activated cell sorting (FACS) was performed utilizing GFP expressed in the presence of the HNF4␣ overexpression plasmid. FACS was performed by the Flow Cytometry Core Facility (KUMC).
Cells were plated at 1.5 ϫ 10 6 cells/plate in 100-mm plates using the same groups as previously discussed. Cells were transfected 24 h after plating and collected 24 h later for sorting based on their expression of GFP using the FACSAria system (BD Biosciences, San Jose, CA). After sorting, total protein (RIPA) and total RNA (TRIzol) were collected for further analysis.
Overexpression of HNF4␣ was measured at the protein level via Western blotting. Promitogenic gene expression was measured using real-time PCR and previously described primer sets (Table 1) .
Cell cycle analysis. Cell cycle analysis was performed on cells transfected with the HNF4␣ overexpression plasmid or the control plasmid, both of which express GFP for selection of positively transfected cells. Cells were plated at 1.5 ϫ 10 6 cells/plate in 100-mm plates, transfected 24 h after plating, and collected for cell cycle analysis 24 h later. Collected cells were fixed with 2% (wt/vol) paraformaldehyde for 1 h at 4°C and then permeabilized with cold 70% ethanol overnight at 4°C. On the following day, cells were stained with propidium iodide (40 g/ml in sterile PBS) for 30 min at 37°C. The cell cycle was then analyzed by the Flow Cytometry Core Facility (KUMC) using the LSR II flow cytometer (BD Biosciences) and Flowjo flow cytometry analysis software.
Statistical analysis. Values are means Ϯ SD. Student's t-test was applied to all analyses. P Ͻ 0.05 was considered significant.
RESULTS
HNF4␣ deletion results in increased cell proliferation.
Treatment of HNF4␣
fl/fl mice with MUP-iCre-AAV8 resulted in deletion of HNF4␣, as demonstrated by Western blot analysis (Fig. 1B) . Data showed a 70 -100% decrease in HNF4␣ protein level following treatment with MUP-iCre-AAV8 com- pared with MUP-EGFP-AAV8. In two of the seven mice studied, we observed partial deletion of HNF4␣; in the rest of the mice, complete deletion of HNF4␣ was achieved. The mice with complete deletion of HNF4␣ were used for all further analysis. Hematoxylin-eosin staining of liver sections indicated no histopathological liver injury following deletion of HNF4␣ (Fig. 2, A and B) . PAS staining revealed decreased hepatic glycogen content following deletion of HNF4␣ (Fig. 2, C and  D) . A concomitant increase in lipid accumulation after HNF4␣ deletion was demonstrated by Oil Red O staining (Fig. 2, E and  F) . HNF4␣ deletion also resulted in a significant increase in hepatocyte proliferation, as demonstrated by PCNA analysis (Fig. 3A) . HNF4␣ deletion resulted in a 15% increase in actively proliferating cells compared with control (Fig. 3B) . The PCNA data were further confirmed by Ki-67-HNF4␣ dual immunofluorescence (Fig. 3C) . Data show a significant increase in the number of Ki-67-positive cells following deletion of HNF4␣.
Increased promitogenic gene expression following deletion of HNF4␣. Gene expression changes were determined by cDNA microarray analysis of liver tissues from mice treated with MUP-EGFP-AAV8 and MUP-iCre-AAV8 (Table 3 ). Table 4 provides a list of the top 20 genes up-or downregulated after HNF4␣ deletion, respectively, sorted according to the fold change in expression. A closer analysis indicates that deletion of HNF4␣ resulted in downregulation of many of the known HNF4␣ target genes involved in classic hepatocyte function, including Cldn1, Tjp3, and Cepbd (2, 3, 10, 32) (Table 5) . Interestingly, a significant number of genes that were upregulated following HNF4␣ deletion are known to be promitogenic, with a large number directly associated with the cell cycle ( Table 6 ). The microarray data were confirmed by real-time PCR for a few selected promitogenic genes (Fig. 4) . These data indicate that loss of HNF4␣ resulted in activation of multiple promitogenic genes, including Egr1, Cdc20, Ccnd1, Ect2, Birc5, Ccnb1, Ccnb2, Ccna2, Cdca3, Eid1, Aurka, Plk1, Ki-67, and Rrm2.
Direct interaction of HNF4␣ with the promoter region of promitogenic genes Ect2, Hjurp, and Osgin1. To determine which of the upregulated genes may be direct HNF4␣ targets, we compared our cDNA microarray data with published ChIP-Seq data (17) . We identified 29 upregulated genes following HNF4␣ deletion that contained a potential HNF4␣ binding site ( Table 7) . As a proof-of-principle, using RT-PCR, we confirmed an upregulation for three of these genes, Ect2, Hjurp, and Osgin1, which are known to be involved in hepatocyte proliferation (24, 28, 30) (Fig. 5A) . ChIP analysis confirmed putative HNF4␣ binding at Ect2, Hjurp, and Osgin1 identified by analysis of previously published ChIP-Seq data (Fig. 5B) . IPA analysis based on gene arrays data had indicated an indirect inhibition of these genes by HNF4␣ (Fig. 5C) . We provide the first evidence that HNF4␣ may be influencing the expression of a subset of promitogenic genes by a direct mechanism. We are currently studying additional genes that may be directly repressed by HNF4␣. Table 7 provides a list of all upregulated genes (potential negative targets of HNF4␣) that have a putative HNF4␣ binding site.
In vitro overexpression of HNF4␣ results in decreased hepatocyte proliferation and downregulation of promitogenic gene expression. To determine if HNF4␣ overexpression results in decreased cell proliferation, we overexpressed HNF4␣ in mouse HCC (Hepa1C1C) cells. The HNF4␣ overexpression plasmid used in these studies also expresses GFP under a separate promoter, allowing selection of transfected cells. The HNF4␣-overexpressing cells were then selected by flow cytometric analysis using GFP as a marker. HNF4␣ overexpression was confirmed at the protein level by Western blot analysis (Fig. 6B) on GFP-selected cell populations.
Using propidium iodide-aided flow cytometric analysis, we next studied the effect of HNF4␣ overexpression on the cell cycle. The overexpression of HNF4␣ resulted in an increased number of cells in the G 0 /G 1 phase of the cell cycle and a decreased number of cells in the G 2 /M phase (Fig. 6C) . Real-time PCR analysis performed on the GFP-selected cells indicated that overexpression of HNF4␣ resulted in decreased expression of multiple cell cycle genes, including Ccnd1, Ccnb1, Ccna2, Ect2, Ki-67, and Rrm2 (Fig. 6D) . These data indicate that overexpression of HNF4␣ results in cell cycle arrest mainly in the G 0 /G 1 phase of the cell cycle.
DISCUSSION
HNF4␣ regulates many of the hepatocyte-specific genes, and its role in hepatic differentiation is well recognized (11, 15, 18 -21) . Recent studies have suggested a role of HNF4␣ in the regulation of hepatocyte proliferation (4, 8, 9, 11, 12, 15, 23, 26, 29, 36) . However, the mechanisms of HNF4␣-mediated inhibition of hepatocyte proliferation remain unknown. In this study, we attempted to elucidate a potential mechanism by which HNF4␣ may have an antiproliferative effect on hepatocytes within the mature mouse liver. We have demonstrated that a loss of HNF4␣ leads to an increase in hepatocyte proliferation in correlation with an increase in promitogenic gene expression.
Previous models of HNF4␣ deletion have resulted in a loss of HNF4␣ relatively early in life, when the liver is still growing and maturing (15, 31) . This may limit the interpretation of the data. Furthermore, none of those studies specifically investigated the role of HNF4␣ in cell proliferation. We developed a model of HNF4␣ deletion in adult mice, where liver maturation is complete and the loss of HNF4␣ would not interfere in postnatal liver development. Our model utilizes the Cre-lox method of deletion with delivery of the Cre recombinase using an AAV8 viral vector under control of a liverspecific mouse promoter (MUP) to HNF4␣ fl/fl mice. Deletion of HNF4␣ did not result in any visible hepatocyte death, neither necrosis nor apoptosis, under histological analysis. However, hepatocytes appeared to contain an increased amount of open space. We speculated that this may be an accumulation of lipid or glycogen. On further investigation, we observed a decrease in glycogen accumulation and an increase in lipid accumulation, which may explain the increased open space within the HNF4␣-null hepatocytes. Furthermore, changes in glycogen and lipid are consistent with gene expression changes involving known hepatic functions involved in the storage and mobilization of each. These data are consistent with the previous observation of Hayhurst et al. (15) using a liver-specific albumin-Cre model. They observed a gradual decrease in HNF4␣ mRNA levels up to about postnatal week 6, with changes in the expression of genes involved in known hepatic functions, such as lipid homeostasis (15) . They spec- ulated that changes in genes involved in lipid metabolism and mobilization may be involved in the accumulation of lipids within the HNF4␣-null hepatocytes. We show here that the same phenomena can be observed as early as 7 days postdeletion within the mature mouse liver, with consistent changes in genes such as Apoa2, Apoa4, Apob, Apoc2, Apoc3, and MTP. We also found consistent changes in genes involved in bile acid homeostasis, such as Cyp7b1, Cyp8b1, NTCP, and Oatp1. After deletion of HNF4␣ in vivo, we observed an increase in hepatocyte proliferation, along with an increase in promitogenic gene expression. Bonzo et al. (5) recently published data using a similar hepatocyte-specific, inducible HNF4␣ deletion model utilizing a tamoxifen-inducible Cre. Our data confirm their findings that HNF4␣ inhibits proliferation through the inhibition of genes involved in cell cycle control. However, their analysis was performed 19 days following initial tamoxifen exposure. Our study strengthens their findings by showing that hepatocyte proliferation and changes in promitogenic gene expression occur as early as 7 days after HNF4␣ deletion. Furthermore, our study indicates that the increased promitogenic gene expression and hepatocyte proliferation may be due directly to the loss of HNF4␣ as opposed to any compensatory mechanisms.
Overexpression of HNF4␣ in vitro yielded a decrease in promitogenic gene expression with what appeared to be an arrest in the cell cycle at the G 0 /G 1 phase. We hypothesize that HNF4␣, which is typically thought of as a positive transcriptional regulator, may be functioning as a negative transcriptional regulator for select genes involved in the inhibition of hepatocyte proliferation. Therefore, HNF4␣ may play a dual role in the mature mouse liver, acting as a transcriptional activator of genes involved in differentiation and as a transcriptional repressor of genes involved in hepatocyte proliferation. A disruption in normal HNF4␣ function could be one contributing factor for liver pathology, such as HCC development.
We have identified a number of genes that are upregulated following HNF4␣ deletion, indicating that they are negatively regulated by HNF4␣. However, the mechanisms by which HNF4␣ negatively regulates these genes remain unknown. Our data indicate that HNF4␣ may be negatively regulating some of these genes, including promitogenic genes such as Ect2, 
